These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18628476)

  • 1. A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway.
    Tiran Z; Oren A; Hermesh C; Rotman G; Levine Z; Amitai H; Handelsman T; Beiman M; Chen A; Landesman-Milo D; Dassa L; Peres Y; Koifman C; Glezer S; Vidal-Finkelstein R; Bahat K; Pergam T; Israel C; Horev J; Tsarfaty I; Ayalon-Soffer M
    Clin Cancer Res; 2008 Jul; 14(14):4612-21. PubMed ID: 18628476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis.
    Abounader R; Laterra J
    Neuro Oncol; 2005 Oct; 7(4):436-51. PubMed ID: 16212809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK1, a natural splice variant of hepatocyte growth factor/scatter factor, is a partial agonist in vivo.
    Jakubczak JL; LaRochelle WJ; Merlino G
    Mol Cell Biol; 1998 Mar; 18(3):1275-83. PubMed ID: 9488442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-apoptotic role of caspase-cleaved GAB1 adaptor protein in hepatocyte growth factor/scatter factor-MET receptor protein signaling.
    Le Goff A; Ji Z; Leclercq B; Bourette RP; Mougel A; Guerardel C; de Launoit Y; Vicogne J; Goormachtigh G; Fafeur V
    J Biol Chem; 2012 Oct; 287(42):35382-35396. PubMed ID: 22915589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44 is required for two consecutive steps in HGF/c-Met signaling.
    Orian-Rousseau V; Chen L; Sleeman JP; Herrlich P; Ponta H
    Genes Dev; 2002 Dec; 16(23):3074-86. PubMed ID: 12464636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HGF/SF increases tumor blood volume: a novel tool for the in vivo functional molecular imaging of Met.
    Tsarfaty G; Stein GY; Moshitch-Moshkovitz S; Kaufman DW; Cao B; Resau JH; Vande Woude GF; Tsarfaty I
    Neoplasia; 2006 May; 8(5):344-52. PubMed ID: 16790083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional map and domain structure of MET, the product of the c-met protooncogene and receptor for hepatocyte growth factor/scatter factor.
    Gherardi E; Youles ME; Miguel RN; Blundell TL; Iamele L; Gough J; Bandyopadhyay A; Hartmann G; Butler PJ
    Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12039-44. PubMed ID: 14528000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MET: a critical player in tumorigenesis and therapeutic target.
    Graveel CR; Tolbert D; Vande Woude GF
    Cold Spring Harb Perspect Biol; 2013 Jul; 5(7):. PubMed ID: 23818496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cMET in the development and progression of colorectal cancer.
    Samamé Pérez-Vargas JC; Biondani P; Maggi C; Gariboldi M; Gloghini A; Inno A; Volpi CC; Gualeni AV; di Bartolomeo M; de Braud F; Castano A; Bossi I; Pietrantonio F
    Int J Mol Sci; 2013 Sep; 14(9):18056-77. PubMed ID: 24005867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semi-synthesis of a HGF/SF kringle one (K1) domain scaffold generates a potent
    Simonneau C; Bérénice Leclercq ; Mougel A; Adriaenssens E; Paquet C; Raibaut L; Ollivier N; Drobecq H; Marcoux J; Cianférani S; Tulasne D; de Jonge H; Melnyk O; Vicogne J
    Chem Sci; 2015 Mar; 6(3):2110-2121. PubMed ID: 28717459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of RNA alternative splicing in regulating cancer metabolism.
    Kozlovski I; Siegfried Z; Amar-Schwartz A; Karni R
    Hum Genet; 2017 Sep; 136(9):1113-1127. PubMed ID: 28429085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A method for identifying discriminative isoform-specific peptides for clinical proteomics application.
    Zhang F; Chen JY
    BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):522. PubMed ID: 27557076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. U1 snRNP-Dependent Suppression of Polyadenylation: Physiological Role and Therapeutic Opportunities in Cancer.
    Spraggon L; Cartegni L
    Int J Cell Biol; 2013; 2013():846510. PubMed ID: 24285958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the Ras-MAPK and PI3K-mTOR Signalling Pathways by Alternative Splicing in Cancer.
    Siegfried Z; Bonomi S; Ghigna C; Karni R
    Int J Cell Biol; 2013; 2013():568931. PubMed ID: 24078813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is fibroblast growth factor receptor 4 a suitable target of cancer therapy?
    Heinzle C; Erdem Z; Paur J; Grasl-Kraupp B; Holzmann K; Grusch M; Berger W; Marian B
    Curr Pharm Des; 2014; 20(17):2881-98. PubMed ID: 23944363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Function of alternative splicing.
    Kelemen O; Convertini P; Zhang Z; Wen Y; Shen M; Falaleeva M; Stamm S
    Gene; 2013 Feb; 514(1):1-30. PubMed ID: 22909801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity.
    Rusnati M; Bugatti A; Mitola S; Leali D; Bergese P; Depero LE; Presta M
    Sensors (Basel); 2009; 9(8):6471-503. PubMed ID: 22454596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of antagonistic soluble decoy receptor tyrosine kinases by intronic polyA activation.
    Vorlová S; Rocco G; Lefave CV; Jodelka FM; Hess K; Hastings ML; Henke E; Cartegni L
    Mol Cell; 2011 Sep; 43(6):927-39. PubMed ID: 21925381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential therapeutics specific to c-MET/RON receptor tyrosine kinases for molecular targeting in cancer therapy.
    Wang MH; Padhye SS; Guin S; Ma Q; Zhou YQ
    Acta Pharmacol Sin; 2010 Sep; 31(9):1181-8. PubMed ID: 20694025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis.
    You WK; McDonald DM
    BMB Rep; 2008 Dec; 41(12):833-9. PubMed ID: 19123972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.